SCHOFIELD, Wis., July 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M conducted by leading headache researcher Dr. Roger Cady, has now been published in the recent July/August print edition of Headache, a top-tier medical journal of the American Headache Society.
